Lantheus Holdings (LNTH) Receivables - Net (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Receivables - Net came in at $355.7 million in Q1 2026, up 1.98% year-on-year from $348.7 million in Q1 2025, and down 0.83% on a QoQ basis from $358.6 million in Q4 2025.
Lantheus Holdings (LNTH) Receivables - Net (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Receivables - Net data on file, last reported at $355.7 million in Q1 2026.
- On a quarterly basis, Receivables - Net rose 1.98% year-over-year to $355.7 million in Q1 2026; TTM through Mar 2026 was $355.7 million, a 1.98% increase from a year earlier, with the FY2025 full-year figure at $358.6 million, up 11.64% from the prior year.
- Receivables - Net for Q1 2026 stood at $355.7 million, down from $358.6 million in the prior quarter.
- Over the last five years, Receivables - Net for LNTH reached as high as $372.3 million in Q2 2024 and fell as low as $172.3 million in Q1 2022.
- Historically, Receivables - Net has averaged $289.6 million across 5 years, with a median of $321.3 million in 2024.
- Across the five-year window, Receivables - Net surged 240.76% in 2022 and retreated 9.59% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $213.4 million in 2022, then jumped by 33.22% to $284.3 million in 2023, then climbed by 13.0% to $321.3 million in 2024, then climbed by 11.64% to $358.6 million in 2025, then slipped by 0.83% to $355.7 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $355.7 million in Q1 2026, $358.6 million in Q4 2025, and $351.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355.67 Mn |
| Mar 31, 2026 | 355.67 Mn |
| Dec 31, 2025 | 358.64 Mn |
| Dec 31, 2025 | 358.64 Mn |
| Sep 30, 2025 | 351.38 Mn |
| Sep 30, 2025 | 351.38 Mn |
| Jun 30, 2025 | 336.58 Mn |
| Jun 30, 2025 | 336.58 Mn |
| Mar 31, 2025 | 348.75 Mn |
| Mar 31, 2025 | 348.75 Mn |
| Dec 31, 2024 | 321.26 Mn |
| Dec 31, 2024 | 321.26 Mn |
| Sep 30, 2024 | 329.34 Mn |
| Sep 30, 2024 | 329.34 Mn |
| Jun 30, 2024 | 372.29 Mn |
| Jun 30, 2024 | 372.29 Mn |
| Mar 31, 2024 | 337.39 Mn |
| Mar 31, 2024 | 337.39 Mn |
| Dec 31, 2023 | 284.29 Mn |
| Dec 31, 2023 | 284.29 Mn |